Vitrolife (VITR.ST) Release: Interim Report January-March 2014: Strengthened Operating Margin
4/23/2014 8:55:55 AM
First quarter in brief:
· Sales growth was 12 percent in local currency. Sales amounted to SEK 119 (105) million, corresponding to an increase of 14 percent in SEK.
· Operating income (EBIT) amounted to SEK 30 (17) million, corresponding to an operating margin of 25 (16) percent.
Operating income included a recovered additional purchase price of SEK 2 million regarding the acquisition of Cryo Management Ltd. Adjusted for this, the operating margin amounted to 23 (16) percent.
Help employers find you! Check out all the jobs and post your resume.
comments powered by